Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Launches Safe Use Initiative; Details To Evolve Through Stakeholder Input

This article was originally published in The Pink Sheet Daily

Executive Summary

Vast scope of project - which will examine everything from operating room procedures to pharmacy leaflets - contrasts with "small" goals for the first year.

You may also be interested in...



Outpatient Rx Safety Meeting To Spotlight Health Literacy, Provider Communication

US FDA has made efforts to improve health communications to cater to deficiencies in literacy; other specific topics for discussion at the meeting remain unclear.

FDA Safety Meetings: Outpatient Drugs, Hypoglycemia Getting Limelight

US agency's events could address a touchy subject: how much responsibility does FDA have for preventing adverse events, and how much falls to physicians?

CDER Outreach Coordinator’s First Task Is Safe Use Initiative

John Whyte joins FDA from Discovery Channel to be director of professional affairs and stakeholder engagement.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068832

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel